46 related articles for article (PubMed ID: 38442088)
21. Management of Renal Cell Carcinoma and Other Renal Masses in the Kidney Graft.
Warren H; Olsburgh J
Curr Urol Rep; 2020 Feb; 21(1):8. PubMed ID: 32048068
[TBL] [Abstract][Full Text] [Related]
22. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.
Park B; Yoon J; Choi D; Kim HJ; Jung YK; Kwon OJ; Lee KG
Sci Rep; 2019 Nov; 9(1):17202. PubMed ID: 31748582
[TBL] [Abstract][Full Text] [Related]
23. Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis.
Chewcharat A; Thongprayoon C; Bathini T; Aeddula NR; Boonpheng B; Kaewput W; Watthanasuntorn K; Lertjitbanjong P; Sharma K; Torres-Ortiz A; Leeaphorn N; Mao MA; Khoury NJ; Cheungpasitporn W
J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30999706
[TBL] [Abstract][Full Text] [Related]
24. Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.
Rousseau B; Guillemin A; Duvoux C; Neuzillet C; Tlemsani C; Compagnon P; Azoulay D; Salloum C; Laurent A; de la Taille A; Salomon L; Cholley I; Haioun C; Dupuis J; Wolkenstein P; Matignon MB; Grimbert P; Tournigand C
Int J Cancer; 2019 Feb; 144(4):886-896. PubMed ID: 30155929
[TBL] [Abstract][Full Text] [Related]
25. Renal cell cancer after kidney transplantation.
Kleine-Döpke D; Oelke M; Schwarz A; Schwager Y; Lehner F; Klempnauer J; Schrem H
Langenbecks Arch Surg; 2018 Aug; 403(5):631-641. PubMed ID: 30003323
[TBL] [Abstract][Full Text] [Related]
26. Association between urologic malignancies and end-stage renal disease: A meta-analysis.
Kompotiatis P; Thongprayoon C; Manohar S; Cheungpasitporn W; Gonzalez Suarez ML; Craici IM; Mao MA; Herrmann SM
Nephrology (Carlton); 2019 Jan; 24(1):65-73. PubMed ID: 29236344
[TBL] [Abstract][Full Text] [Related]
27. Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers.
Cheung CY; Man Ma MK; Chak WL; Chau KF; Tang SCW
Oncotarget; 2017 Jul; 8(27):44833-44841. PubMed ID: 28160552
[TBL] [Abstract][Full Text] [Related]
28. Bacterial urinary tract infection in renal transplant recipients and their antibiotic resistance pattern: A four-year study.
Khosravi AD; Abasi Montazeri E; Ghorbani A; Parhizgari N
Iran J Microbiol; 2014 Apr; 6(2):74-8. PubMed ID: 25705355
[TBL] [Abstract][Full Text] [Related]
29. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.
Knoll GA; Kokolo MB; Mallick R; Beck A; Buenaventura CD; Ducharme R; Barsoum R; Bernasconi C; Blydt-Hansen TD; Ekberg H; Felipe CR; Firth J; Gallon L; Gelens M; Glotz D; Gossmann J; Guba M; Morsy AA; Salgo R; Scheuermann EH; Tedesco-Silva H; Vitko S; Watson C; Fergusson DA
BMJ; 2014 Nov; 349():g6679. PubMed ID: 25422259
[TBL] [Abstract][Full Text] [Related]
30. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.
Alberú J; Pascoe MD; Campistol JM; Schena FP; Rial Mdel C; Polinsky M; Neylan JF; Korth-Bradley J; Goldberg-Alberts R; Maller ES;
Transplantation; 2011 Aug; 92(3):303-10. PubMed ID: 21792049
[TBL] [Abstract][Full Text] [Related]
31. A Rare Case of Donor-Derived Renal Cell Carcinoma in a Kidney Transplant Recipient.
Sebastian W; Omar KO; Anees R; Nagaraju S; Chaitanya M
Am J Case Rep; 2024 Mar; 25():e941214. PubMed ID: 38442088
[TBL] [Abstract][Full Text] [Related]
32. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.
Su MZ; Campbell NA; Lau HM
Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature.
Cheung CY; Lam MF; Lee KC; Chan GS; Chan KW; Chau KF; Li CS; Chan TM; Lai KN
Int Urol Nephrol; 2011 Sep; 43(3):675-80. PubMed ID: 21547472
[TBL] [Abstract][Full Text] [Related]
34. [Renal neoplasms and renal transplantation: current problems and future perspectives].
Carrieri G; Netti GS; Perrone A; Stallone G; Selvaggi FP; Gesualdo L
G Ital Nefrol; 2004; 21(6):547-53. PubMed ID: 15593022
[TBL] [Abstract][Full Text] [Related]
35. Nephron Sparing Surgery in Renal Allograft in Recipients with de novo Renal Cell Carcinoma: Two Case Reports and Review of the Literature.
Hubatsch M; Peters R; Maxeiner A; El-Bandar N; Weinberger S; Friedersdorff F
Urol Int; 2020; 104(11-12):997-999. PubMed ID: 32966984
[TBL] [Abstract][Full Text] [Related]
36. [Urologic malignancies in renal transplant candidates and recipients].
Kleinclauss F; Thuret R; Murez T; Timsit MO
Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
[TBL] [Abstract][Full Text] [Related]
37. Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management.
Griffith JJ; Amin KA; Waingankar N; Lerner SM; Delaney V; Ames SA; Badani K; Palese MA; Mehrazin R
Am J Transplant; 2017 Nov; 17(11):2775-2781. PubMed ID: 28544435
[TBL] [Abstract][Full Text] [Related]
38. Renal cell carcinoma of native kidneys in renal transplant patients.
Klatte T; Marberger M
Curr Opin Urol; 2011 Sep; 21(5):376-9. PubMed ID: 21730855
[TBL] [Abstract][Full Text] [Related]
39. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
[TBL] [Abstract][Full Text] [Related]
40. Treatment options and outcome for renal cell tumors in the transplanted kidney.
Diller R; Senninger N
Int J Artif Organs; 2008 Oct; 31(10):867-74. PubMed ID: 19009504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
